Literature DB >> 8007962

Dual modes of control of c-fos mRNA induction by intracellular calcium in T cells.

G Lee1, M Gilman.   

Abstract

Cytoplasmic calcium is a nearly universal second messenger in eukaryotes. In many cell types, elevated intracellular calcium interacts synergistically with inducers of protein kinase C to elicit activation of complete biological programs normally induced by extracellular signals. In T cells, elevated cytoplasmic calcium is a critical mediator of activation in response to stimulation of the antigen receptor, and in some T-cell lines, treatment with a combination of calcium ionophore and protein kinase C activator mimics authentic antigen treatment. The synergistic interaction of calcium and protein kinase C in T cells is also observed at the level of gene expression. Here we examine the molecular mechanisms through which these agents exert synergistic control over the expression of the c-fos proto-oncogene in a T-cell hybridoma. We find that the principal effect of calcium is on the elongation of c-fos transcripts. This step constitutes the major control of c-fos mRNA accumulation in these cells. In addition, calcium regulates the initiation of c-fos transcription. This effect requires the serum response element of the c-fos gene and an additional sequence immediately 3' to this element. Thus, calcium regulates c-fos expression through at least two distinct molecular pathways.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8007962      PMCID: PMC358830          DOI: 10.1128/mcb.14.7.4579-4587.1994

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  71 in total

Review 1.  Molecular and genetic insights into T cell antigen receptor structure and function.

Authors:  A Weiss
Journal:  Annu Rev Genet       Date:  1991       Impact factor: 16.830

2.  A protein binding site from the murine c-myc promoter contributes to transcriptional block.

Authors:  D Dufort; M Drolet; A Nepveu
Journal:  Oncogene       Date:  1993-01       Impact factor: 9.867

3.  A common nuclear signal transduction pathway activated by growth factor and cytokine receptors.

Authors:  H B Sadowski; K Shuai; J E Darnell; M Z Gilman
Journal:  Science       Date:  1993-09-24       Impact factor: 47.728

4.  Regulation of gene expression in hippocampal neurons by distinct calcium signaling pathways.

Authors:  H Bading; D D Ginty; M E Greenberg
Journal:  Science       Date:  1993-04-09       Impact factor: 47.728

5.  FK-506- and CsA-sensitive activation of the interleukin-2 promoter by calcineurin.

Authors:  S J O'Keefe; J Tamura; R L Kincaid; M J Tocci; E A O'Neill
Journal:  Nature       Date:  1992-06-25       Impact factor: 49.962

6.  Identification of calcineurin as a key signalling enzyme in T-lymphocyte activation.

Authors:  N A Clipstone; G R Crabtree
Journal:  Nature       Date:  1992-06-25       Impact factor: 49.962

7.  Phosphorylation of transcription factor p62TCF by MAP kinase stimulates ternary complex formation at c-fos promoter.

Authors:  H Gille; A D Sharrocks; P E Shaw
Journal:  Nature       Date:  1992-07-30       Impact factor: 49.962

8.  The block to transcriptional elongation within the human c-myc gene is determined in the promoter-proximal region.

Authors:  A Krumm; T Meulia; M Brunvand; M Groudine
Journal:  Genes Dev       Date:  1992-11       Impact factor: 11.361

9.  Ras-independent growth factor signaling by transcription factor tyrosine phosphorylation.

Authors:  O Silvennoinen; C Schindler; J Schlessinger; D E Levy
Journal:  Science       Date:  1993-09-24       Impact factor: 47.728

10.  Activation of ternary complex factor Elk-1 by MAP kinases.

Authors:  R Janknecht; W H Ernst; V Pingoud; A Nordheim
Journal:  EMBO J       Date:  1993-12-15       Impact factor: 11.598

View more
  9 in total

1.  Ral GTPases contribute to regulation of cyclin D1 through activation of NF-kappaB.

Authors:  D O Henry; S A Moskalenko; K J Kaur; M Fu; R G Pestell; J H Camonis; M A White
Journal:  Mol Cell Biol       Date:  2000-11       Impact factor: 4.272

2.  Action potential-dependent regulation of gene expression: temporal specificity in ca2+, cAMP-responsive element binding proteins, and mitogen-activated protein kinase signaling.

Authors:  R D Fields; F Eshete; B Stevens; K Itoh
Journal:  J Neurosci       Date:  1997-10-01       Impact factor: 6.167

3.  Voltage-insensitive Ca2+ channels and Ca2+/calmodulin-dependent protein kinases propagate signals from endothelin-1 receptors to the c-fos promoter.

Authors:  Y Wang; M S Simonson
Journal:  Mol Cell Biol       Date:  1996-10       Impact factor: 4.272

4.  Stimulation of the Ca2+-mediated egr-1 and c-fos expression in murine erythroleukaemia cells by cyclosporin A.

Authors:  A Schaefer; M Magócsi; A Fandrich; H Marquardt
Journal:  Biochem J       Date:  1998-11-01       Impact factor: 3.857

5.  CREB, AP-1, ternary complex factors and MAP kinases connect transient receptor potential melastatin-3 (TRPM3) channel stimulation with increased c-Fos expression.

Authors:  Sandra Rubil; Oliver G Rössler; Gerald Thiel
Journal:  Br J Pharmacol       Date:  2015-12-19       Impact factor: 8.739

6.  A novel mouse c-fos intronic promoter that responds to CREB and AP-1 is developmentally regulated in vivo.

Authors:  Vincent Coulon; Karim Chebli; Patricia Cavelier; Jean-Marie Blanchard
Journal:  PLoS One       Date:  2010-06-21       Impact factor: 3.240

7.  Cross-linking CD40 on B cells preferentially induces stress-activated protein kinases rather than mitogen-activated protein kinases.

Authors:  I Berberich; G Shu; F Siebelt; J R Woodgett; J M Kyriakis; E A Clark
Journal:  EMBO J       Date:  1996-01-02       Impact factor: 11.598

8.  Calcium signaling and transcription: elongation, DoGs, and eRNAs.

Authors:  Anna Vilborg; Maria C Passarelli; Joan A Steitz
Journal:  Receptors Clin Investig       Date:  2016-02-01

9.  Activation protein 1-dependent transcriptional activation of interleukin 2 gene by Ca2+/calmodulin kinase type IV/Gr.

Authors:  N Ho; M Gullberg; T Chatila
Journal:  J Exp Med       Date:  1996-07-01       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.